✦ LIBER ✦

Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor α blocker therapy

✍ Scribed by Gonzalez-Juanatey, Carlos ;Llorca, Javier ;Vazquez-Rodriguez, Tomas R. ;Diaz-Varela, Nicolas ;Garcia-Quiroga, Hermitas ;Gonzalez-Gay, Miguel A.

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 68 KB
Volume: 59
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.24308

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in patient-reported outcomes

Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy

✍ Keystone, E. ;Burmester, G. R. ;Furie, R. ;Loveless, J. E. ;Emery, P. ;Kremer, J 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB 👁 1 views

Active but transient improvement of endo

Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor α antibody

✍ Gonzalez-Juanatey, Carlos ;Testa, Ana ;Garcia-Castelo, Alberto ;Garcia-Porrua, C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract ## Objective Cardiovascular disease is the major cause of excessive mortality in rheumatoid arthritis (RA). Atherosclerosis and RA share similar inflammatory mechanisms that include involvement of tumor necrosis factor α (TNFα). Anti‐TNFα antibody improved endothelial function in RA pa